Expression of the MDR1 gene product P-glycoprotein in childhood neuroblastoma

Cancer

Volumn 80, Issue 7, 1997, Pages 1250-1257

  Dhooge, Catharina R M ^a   De Moerloose, Barbara M J ^b   Benoit, Yves C M ^a   Van Roy, Nadine ^a   Philippé, Jan ^a   Laureys, Geneviève G M ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b Aspirant NFWO   (Belgium)

Author keywords

MDR1; Metastasis; Multidrug resistance; Neuroblastoma; P glycoprotein; P gp; Prognostic factors

Indexed keywords

GLYCOPROTEIN P;

ADOLESCENT; ARTICLE; CANCER CHEMOTHERAPY; CANCER RECURRENCE; CHILD; CONTROLLED STUDY; GENE EXPRESSION; HISTOLOGY; HUMAN; INFANT; MAJOR CLINICAL STUDY; METASTASIS; MULTIDRUG RESISTANCE; NEUROBLASTOMA; PRIORITY JOURNAL; PROGNOSIS; THERAPY RESISTANCE; TUMOR DIFFERENTIATION;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE MARROW NEOPLASMS; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; DRUG RESISTANCE, MULTIPLE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, MDR; HUMANS; INFANT; NEUROBLASTOMA; P-GLYCOPROTEIN; PLOIDIES; PROGNOSIS; TREATMENT OUTCOME;

EID: 0030924515     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19971001)80:7<1250::AID-CNCR8>3.0.CO;2-O     Document Type: Article

References (21)

1. Kartner N, Evernden-Porelle D, Bradley G. Detection of P-glycoprotein in multidrug resistant cell lines by monoclonal antibodies. Nature 1985;316:820-3.
2. Callen D, Baker E, Simmers RN. Localisation of the human multiple drug resistance gene mdr to 7q21.1. Hum Genet 1987;77:142-214.
3. Thiebaut F, Tsuruo T, Hamada H, Gottesman MM, Pastan I, Willingham MC. Cellular localisation of the multidrug resistance gene product P-glycoprotein in normal human tissues. Proc Natl Acad Sci USA 1987;84:7735-8.
4. Gerlach J, Bell DR, Karakousis C. P-glycoprotein in human sarcoma: evidence for multidrug resistance. J Clin Oncol 1987;5:1452-60.
5. Weinstein R, Grogan T, Kuszak J. Multidrug resistance gene product (P-glycoprotein) in normal tissue and tumors. Adv Pathol Lab Med 1991;207-34.
6. Chan HS, Haddad G, Thorner PS, DeBoer G, Ping Lin Y, Ondrusek N, et al. P-glycoprotein expression as a predictor of the outcome of therapy for neuroblastoma. N Engl J Med 1991;325:1608-14.
7. Nakagawara A, Kadomatsu K, Sato S, Kohno K, Takano H, Akazawa K, et al. Inverse correlation between expression of multidrug resistance gene and MYCN oncogene in human neuroblastomas. Cancer Res 1990;50:3043-7.
8. Bordow S, Haber M, Madafiglio J. Expression of the multidrug resistance-associated protein (MRP) gene correlates with amplification and overexpression of the MYCN oncogene in childhood neuroblastoma. Cancer Res 1994;54:5036-40.
9. Cooke HJ, Hindley J. Cloning of human satellite III DNA: different components are on different chromosomes. Nucleic Acids Res 1979;6:3177-9.
10. Buroker N, Bestwick R, Haight G, Magenis RE, Litt M. A hypervariable repeated sequence on human chromosome 1p36. Hum Genet 1987;77:175-81.
11. Speleman F, Leroy JG, Van Roy N, Hilliker C, Suijkerbuijk RF, De Vos E. Molecular cytogenetic analysis of a familial half cryptic pericentric inversion of chromosome 12. Clin Genet 1993;44:156-63.
12. Dhooge C, De Moerloose B, De Potter C, Laureys G, Benoit Y, Leroy J. Expression of the multidrug transporter, P-glycoprotein, in childhood leukemia: a prospective clinical study. Int J Pediatr Hematol/Oncol 1994;1:311-4.
13. Chan HS, Bradley G, Thorner P, Haddad G, Gallie BL, Ling V. A sensitive method for immunocytochemical detection of P-glycoprotein in multidrug-resistant human ovarian carcinoma cell line. Lab Invest 1988;59:870-5.
14. Arceci RJ, Stieglitz K, Bras J. A monoclonal antibody to an external epitope of the P-glycoprotein. Cancer Res 1993; 53:310-7.
15. Nielsen D, Skovsgaard T. P-glycoprotein as multidrug transporter: a critical review of current multidrug resistant cell lines. Biochim Biophys Acta 1992;1139:169-83.
16. Bénard J, Bourhis J, de Vathaire F. Prognostic value of MDR1 gene expression in neuroblastoma: results of a multivariate analysis. Adv Neuroblast Res 1994;4:111-6.
17. Herzog CE, Trepel JB, Mickley LA. Various methods of analysis of mdr1/P-gp in human cancer cell lines. J Natl Cancer Inst 1992;84:711-6.
18. van der Heyden S, Gheuens E, De Bruijn E, Van Oosterom A, Maes R. P-glycoprotein: clinical significance and methods of analysis. Crit Rev Clin Lab Sci 1995;32(3):221-64.
19. Bénard J, Bourhis J, Riou G. Clinical significance of multidrug resistance in human cancers. Anticancer Res 1990;10:1297-302.
20. Bates SE, Mickley L, Chen Y, Richert N, Rudick J, Biedler J, et al. Expression of a drug resistance gene in human neuroblastoma cell lines: modulation by retinoid acid-induced differentiation. Mol Cell Biol 1989;9:4337-44.
21. Ferrandis E, Da Silva J, Riou G, Bénard I. Coactivation of the MDR1 and MYCN genes in human neuroblastoma cells during the metastatic process in the nude mouse. Cancer Res 1994;54:2256-61.